Preliminary experience with the domestic Jingfeng single-port robotic system for robot-assisted radical prostatectomy

Objective To investigate the clinical feasibility and safety of the domestic Jingfeng single-port robotic surgical systems in robot-assisted radical prostatectomy. Methods A retrospective analysis was conducted on the clinical data of 18 patients who underwent single-port robotic-assisted surgeries at the First Affiliated Hospital of Anhui Medical University from March 1 to May 31, 2025. The procedures included single-port robotic-assisted radical prostatectomy (SP-RARP) (n = 18). The preoperative patient's age, body mass index (BMI), prostate volume, preoperative prostate-specific antigen (PSA), Gleason score, operative time (OT), estimated blood loss (EBL), length of stay (LOS), and duration of catheterization were collected. Results All 18 patients with SP-RARP successfully completed the operations. The mean age was 67.6 ± 7.9 years, and the mean BMI was 22.76 ± 2.37 kg/m 2 . The median (interquartile range, IQR) preoperative PSA was 8.2 (6.6, 11.4) ng/mL, and the median (IQR) preoperative prostate volume on MRI was 31.3 (22.6, 37.5) cm 3 . Among the perioperative indicators, the mean OT was 136.83 ± 43.77 min; the median (IQR) EBL was 35.0 (15.0, 77.5) mL; the median (IQR) LOS was 4 (3, 4) days; and the median (IQR) duration of catheterization was 3 (3, 3) days. Only 4 of them used NSAIDs during hospitalization, accounting for 22.2%. The Clavien-Dindo grades of all patients were Grade Ⅰ. No positive postoperative pathologic margins were found in any patients. No conversion to open surgery or serious complications occurred during the perioperative period. Conclusion Domestic Jingfeng single-port robotic surgical system demonstrate good safety and efficacy in urology, but larger sample size, multicenter, randomized controlled clinical studies are still needed to further validate their effects.